A fibre-optic probe which measures the amount of oxygen in tumours may help
doctors to reduce the side effects of chemotherapy. Tumours with high oxygen
levels are more susceptible to treatment, so researchers at Mount Vernon
Hospital, Middlesex, hope the probe will allow them to identify tumours which
require less chemotherapy and radiotherapy. The probe, called Oxylite, was
invented by Oxford Optronix. Its clinical development is being funded by the
Cancer Research Fund.
More from New Scientist
Explore the latest news, articles and features
Environment
Galapagos corals suggest climate change drives stronger El Ni帽os
News
Life
Astonishing whale feeding frenzy seen off the eastern coast of Greenland
News
Environment
Octopuses released into Adriatic Sea to tackle invasive crabs
News
Technology
Driving data can predict crash black spots before accidents happen
News
Popular articles
Trending New Scientist articles